Similar Search Results

Bundling among rivals : a case of pharmaceutical cocktails

Lucarelli, Claudio; Nicholson, Sean; Song, Minjae - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. We empirically analyze the welfare effects of cross-firm bundling in the pharmaceutical industry. Physicians often treat patients with...

Persistent link: https://www.econbiz.de/10008695771

Mergers and acquisitions in the pharmaceutical and biotech industries

Danzon, Patricia Munch; Epstein, Andrew; Nicholson, Sean - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 307-328

Persistent link: https://www.econbiz.de/10003543650

The Oxford handbook of the economics of the biopharmaceutical industry

Danzon, Patricia Munch (ed.); Nicholson, Sean (contributor) - 2012

Persistent link: https://www.econbiz.de/10009551494

Pharmaceutical strategy and the evolving role of merger and acquisition

Burns, Lawton Robert; Nicholson, Sean; Wolkowski, Joanna P. - In: The business of healthcare innovation, (pp. 116-193). 2012

Persistent link: https://www.econbiz.de/10009618803

Biotech-pharmaceutical alliances as a signal of assetand firm quality

Nicholson, Sean; Danzon, Patricia Munch; McCullough, Jeffrey - In: The journal of business : B 78 (2005) 4, pp. 1433-1464

Persistent link: https://www.econbiz.de/10003172811

Productivity in pharmaceutical-biotechnology R&D : the role of experience and alliances

Danzon, Patricia Munch; Nicholson, Sean; Pereira, Nuno Sousa - In: Journal of health economics 24 (2005) 2, pp. 317-339

Persistent link: https://www.econbiz.de/10002638165

Mergers and acquisitions in the pharmaceutical and biotech industries

Danzon, Patricia Munch; Epstein, Andrew; Nicholson, Sean - 2004

Persistent link: https://www.econbiz.de/10002104576

Productivity in pharmaceutical-biotechnology R&D : the role of experience and alliances

Danzon, Patricia Munch; Nicholson, Sean; Pereira, Nuno Sousa - 2003

Persistent link: https://www.econbiz.de/10001753253

Biotech-pharmaceutical alliances as a signal of asset and firm quality

Nicholson, Sean; Danzon, Patricia Munch; McCullough, … - 2002

Persistent link: https://www.econbiz.de/10001676610

Bundling Among Rivals : A Case of Pharmaceutical Cocktails

Lucarelli, Claudio - 2010

We empirically analyze the welfare effects of cross-firm bundling in the pharmaceutical industry. Physicians often treat patients with "cocktail" regimens that combine two or more drugs. Firms cannot price discriminate because each drug is produced by a different firm and a physician creates the...

Persistent link: https://www.econbiz.de/10013138761